A Disease Registry of Patients With Mantle Cell Lymphoma

CompletedOBSERVATIONAL
Enrollment

229

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

March 18, 2024

Study Completion Date

March 18, 2024

Conditions
Mantle Cell Lymphoma
Trial Locations (32)

10022

Research Site, New York

13057

Research Site, East Syracuse

17822

Research Site, Danville

19104

Research Site, Philadelphia

19111

Research Site, Philadelphia

26506

Research Site, Morgantown

30322

Research Site, Atlanta

30912

Research Site, Augusta

32256

Research Site, Jacksonville

32503

Research Site, Pensacola

36101

Research Site, Montgomery

37232

Research Site, Nashville

48109

Research Site, Ann Arbor

52242

Research Site, Iowa City

53226

Research Site, Milwaukee

55102

Research Site, Saint Paul

55416

Research Site, Saint Louis Park

55805

Research Site, Duluth

60612

Research Site, Chicago

68510

Research Site, Lincoln

75231

Research Site, Dallas

75390

Research Site, Dallas

77030

Research Site, Houston

78229

Research Site, San Antonio

93611

Research Site, Clovis

98122

Research Site, Seattle

80303-1385

Research Site, Boulder

33612-9497

Research Site, Tampa

07922

Research Site, Berkeley Heights

07601

Research Site, Hackensack

97401-8122

Research Site, Eugene

98195-9472

Research Site, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY